Master One Thing - Rapamycin Longevity Series cover image

Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

Master One Thing - Rapamycin Longevity Series

00:00

Plans for the Rapa Mysen trial and considerations for the study population

Discussion on plans to start the Rapa Mysen trial, which aims to examine a wide range of aging parameters, with a focus on inflammatory markers. The chapter also mentions the potential positive response of older individuals in similar studies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app